gentamycin

ゲンタマイシン

関

gentamicin、gentamicin sulfate

WordNet

1. an antibiotic (trade name Garamycin) that is derived from an actinomycete; used in treating infections of the urinary tract (同)Garamycin

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2014/11/08 22:12:26」(JST)

wiki en

[Wiki en表示]

Gentamicin

Systematic (IUPAC) name
(3R,4R,5R)-2-{[(1S,2S,3R,4S,6R)-4,6- diamino-3-{[(2R,3R,6S)- 3-amino-6-[(1R)- 1-(methylamino)ethyl]oxan-2-yl]oxy}- 2-hydroxycyclohexyl]oxy}-5-methyl- 4-(methylamino)oxane-3,5-diol
Clinical data
AHFS/Drugs.com	monograph
MedlinePlus	a682275
Pregnancy cat.	D
Legal status	UK: POM
Routes	IV, Ophthalmic, IM, topical
Pharmacokinetic data
Bioavailability	limited oral bioavailability
Protein binding	0-10%
Half-life	2 hrs
Excretion	renal
Identifiers
CAS number	1403-66-3 Y
ATC code	D06AX07 J01GB03 S01AA11 S02AA14 S03AA06 QA07AA91 QG01AA91 QG51AA04 QJ51GB03
PubChem	CID 3467
IUPHAR ligand	2427
DrugBank	DB00798
ChemSpider	390067 Y
UNII	T6Z9V48IKG Y
KEGG	D08013 Y
ChEBI	CHEBI:27412 Y
ChEMBL	CHEMBL195892 Y
Chemical data
Formula	C21H43N5O7
Mol. mass	477.596 g/mol
SMILES O[C@]3(C)[C@H](NC)[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]1O[C@H](C(NC)C)CC[C@H]1N)[C@@H]2O)OC3
InChI InChI=1S/C21H43N5O7/c1-9(25-3)13-6-5-10(22)19(31-13)32-16-11(23)7-12(24)17(14(16)27)33-20-15(28)18(26-4)21(2,29)8-30-20/h9-20,25-29H,5-8,22-24H2,1-4H3/t9?,10-,11+,12-,13+,14+,15-,16-,17+,18-,19-,20-,21+/m1/s1 Y Key:CEAZRRDELHUEMR-URQXQFDESA-N Y
N (what is this?)  (verify)

Gentamicin is an aminoglycoside antibiotic composed of a mixture of related gentamicin components and fractions and is used to treat many types of bacterial infections, particularly those caused by Gram-negative organisms. However, gentamicin is not used for Neisseria gonorrhoeae, Neisseria meningitidis, or Legionella pneumophila. Gentamicin is also ototoxic and nephrotoxic, with this toxicity remaining a major problem in clinical use.

It is synthesized by Micromonospora, a genus of Gram-positive bacteria widely present in the environment (water and soil). To highlight their specific biological origins, gentamicin and other related antibiotics produced by this genus (verdamicin, mutamicin, sisomicin, netilmicin, retymicin) generally have their spellings ending in ~micin and not in ~mycin. Gentamicin is a bactericidal antibiotic that works by binding the 30S subunit of the bacterial ribosome, interrupting protein synthesis.

Like all aminoglycosides, when gentamicin is given orally, it is not systemically active. This is because it is not absorbed to any appreciable extent from the small intestine. It is administered intravenously, intramuscularly or topically to treat infections. It appears to be completely eliminated unchanged in the urine. Urine must be collected for many days to recover all of a given dose because the drug binds avidly to certain tissues.

E. coli has shown some resistance to gentamicin, despite being Gram-negative. Enzyme inactivation also causes bacterial resistance. Reluctance to use gentamicin for empirical therapy has led to increased use of alternative broad-spectrum antibiotics, which some experts suggest has led to the prevalence of antibiotic-resistant bacterial infections by MRSA and other so-called "superbugs".

Gentamicin is one of the few heat-stable antibiotics that remain active even after autoclaving, which makes it particularly useful in the preparation of some microbiological growth media. It is used during orthopaedic surgery when high temperatures are required for the setting of cements (e.g. hip replacements).

It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.

Medical uses

Active against a wide range of human bacterial infections, mostly Gram-negative bacteria including Pseudomonas, Proteus, Serratia, and the Gram-positive Staphylococcus. Gentamicin is not used for Neisseria gonorrhoeae, Neisseria meningitidis or Legionella pneumophila bacterial infections (because of the risk of the patient going into shock from lipid A endotoxin found in certain Gram-negative organisms). Gentamicin is also useful against Yersinia pestis, its relatives, and Francisella tularensis (the organism responsible for Tularemia seen often in hunters and/or trappers). Some Enterobacteriaceae, Pseudomonas spp., enterococci, Staphylococcus aureus and other staphylococci are resistant to Gentamicin Sulfate, USP to varying degrees.

Side effects

Aminoglycosides are toxic to the sensory cells of the ear, but they vary greatly in their relative effects on hearing versus balance. Gentamicin is a vestibulotoxin, and can cause permanent loss of equilibrioception, caused by damage to the vestibular apparatus of the inner ear, usually if taken at high doses or for prolonged periods of time, but there are well documented cases in which gentamicin completely destroyed the vestibular apparatus after three to five days. A small number of affected individuals have a normally harmless mutation in their mitochondrial DNA encoding the 12S ribosomal RNA (m.1555 A>G), that allows the gentamicin to affect their cells. The cells of the ear are particularly sensitive to this, sometimes causing complete hearing loss. However, gentamicin is sometimes used intentionally for this purpose in severe Ménière's disease, to disable the vestibular apparatus. These side effects are most common when the drug is administered via drops directly to the ear.

Side effects of gentamicin toxicity vary from patient to patient. Side effects may become apparent shortly after or up to months after gentamicin is administered. Symptoms of gentamicin toxicity include:

• Balance difficulty
• Bouncing, unsteady vision
• Ringing in the ears (tinnitus)
• Difficulty multi-tasking, particularly when standing

Gentamicin is nephrotoxic. Risk factors for aminoglycoside nephrotoxicity include patient factors such as:

• increased age
• reduced renal function
• pregnancy
• hypothyroidism
• hepatic dysfunction
• volume depletion
• metabolic acidosis
• concurrent use of other drugs: vancomycin, NSAIDs, cisplatim, cyclosporin, cephalosporin, diuretics
• Concurrent use of iodinated contrast agents

Treatment factors can also affect toxicity. Important factors such as dose, frequency, levels and duration of therapy can affect level of toxicity.

Prevention of nephrotoxicity includes judicouss use of IV fluids to correct and avoid volume depletion, correction of hypokalemia and hypomagnesemia. Once daily dosing has been shown to be less toxic than multiple daily doses. Gentamicin is usually dosed by ideal body weight. Various formulae exist for calculating gentamicin dosage. Trough and peak serum levels of gentamicin are monitored during treatment to individualize therapy and prevent excess exposure.

Gentamicin, like other aminoglycosides, causes nephrotoxicity by inhibiting protein synthesis in renal cells. This mechanism specifically causes necrosis of cells in the proximal tubule, resulting in acute tubular necrosis which can lead to acute renal failure.

Psychiatric symptoms related to gentamicin can occur. These include anorexia, confusion, depression, disorientation and visual hallucinations. Immediate professional help should be sought if any of these symptoms or others appear after administration of aminoglycosides. General medical practitioners should refer patients with such symptoms to an otolaryngologist, commonly known as an 'ear, nose, and throat doctor', for comprehensive tests.

A number of factors and determinants should be taken into account when using gentamicin, including differentiation between empirical and directed therapy which will affect dosage and treatment period. Many medical practitioners freely administer gentamicin as an antibiotic without advising patients of the severe and permanent potential ramifications of its use. Gentamicin is well known to be a cheap, low-cost yet old medicine when compared with modern alternatives, and is typically US$3–6 per dosage less than modern alternatives.

Many people recover from gentamicin toxicity naturally over time if the drug is discontinued, but they recover slowly and usually incompletely. Sometimes the toxicity of gentamicin can still increase over months after the last dose. Upon cessation of gentamicin therapy symptoms such as tinnitus and imbalance may become less pronounced. Sensori-neural hearing loss caused by gentamicin toxicity is permanent however.

Mechanism of action

Gentamicin is a bactericidal antibiotic that works by irreversibly binding the 30S subunit of the bacterial ribosome, interrupting protein synthesis. This mechanism of action is similar to other Aminoglycosides

Gentamicin C complex and related components

Gentamicin is composed of a number of related gentamicin components and fractions which have varying degrees of antimicrobial potency. The main components of gentamicin include members of the gentamicin C complex: gentamicin C1, gentamicin C1a, and gentamicin C2 which compose approximately 80% of gentamicin and have been found to have the highest antibacterial activity. Gentamicin A, B, X, and a few others make up the remaining 20% of gentamicin and have lower antibiotic activity than the gentamicin C complex. The exact composition of a given sample or lot of gentamicin is not well defined, and the level of gentamicin C components or other components in gentamicin may differ from lot-to-lot depending on the gentamicin manufacturer or manufacturing process. Because of this lot-to-lot variability, it can be difficult to study various properties of gentamicin including pharmacokinetics and microorganism susceptibility if there is an unknown combination of chemically related but different compounds.

Production and usage in research

Gentamicin is produced by the fermentation of Micromonospora purpurea. It was discovered in 1963 by Weinstein, Wagman et al. at Schering Corporation in Bloomfield, N.J. working with source material (soil samples) provided by Rico Woyciesjes. Subsequently it was purified and the structures of its three components determined by Cooper, et al., also at the Schering Corporation. It was initially used as a topical treatment for burns at the Atlanta and San Antonio burn units and was introduced into IV usage in 1971. It remains a mainstay for use in sepsis.

Gentamicin is also used in molecular biology research as an antibacterial agent in tissue and cell culture, to prevent contamination of sterile cultures.

Gentamicin for injection

References

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. アミノグリコシド（非経口）の用量および投与 dosing and administration of parenteral aminoglycosides
• 2. Suspected Staphylococcus aureus skin and soft tissue infections: Evaluation and management in neonates
• 3. 重症筋無力症患者に対する麻酔 anesthesia for the patient with myasthenia gravis
• 4. アミノグリコシド aminoglycosides
• 5. 固有弁心内膜炎の抗菌療法 antimicrobial therapy of native valve endocarditis

English Journal

• Prevalence and antibiotic resistance pattern of urinary tract bacterial infections in Dessie area, Northeast Ethiopia.

• Abejew AA, Denboba AA, Mekonnen AG.
• BMC research notes.BMC Res Notes.2014 Oct 3;7(1):687. [Epub ahead of print]
• BACKGROUND: Different studies have indicated that urinary tract infections frequently occur in both community and hospital environments and are of the most common bacterial infections in humans. the outcomes of urinary tract infections are increased hospitalization, increased direct patient costs an
• PMID 25280498

• pRb phosphorylation regulates the proliferation of supporting cells in gentamicin-damaged neonatal avian utricle.

• Wu J1, Sun S, Li W, Chen Y, Li H.
• Neuroreport.Neuroreport.2014 Oct 1;25(14):1144-50. doi: 10.1097/WNR.0000000000000241.
• The ability of nonmammalian vertebrates to regenerate hair cells (HCs) after damage-induced HC loss has stimulated and inspired research in the field of HC regeneration. The protein pRb encoded by retinoblastoma gene Rb1 forces sensory progenitor cells to exit cell cycle and maintain differentiated
• PMID 25100553

• Antimicrobial susceptibility and resistance mechanisms of methicillin resistant staphylococcus aureus isolated from 12 Hospitals in Turkey.

• Y Ld Z O, Coban A, Ener A, Co Kuner S, Bayramo Lu G, Güdücüo Lu H, Ozyurt M, Tatman-Otkun ME, Karabiber N, Ozkütük N, Aktepe O, Oncü S, Arslan UU, Bozdo An B.
• Annals of clinical microbiology and antimicrobials.Ann Clin Microbiol Antimicrob.2014 Sep 16;13(1):44. [Epub ahead of print]
• IntroductionMethicillin-resistant Staphylococcus aureus (MRSA) is one of the most important nosocomial pathogens and is also emerging in Turkish hospitals. The aim of this study was to determine the antimicrobial susceptibility profiles of MRSA isolated from Turkish hospitals.Materials and methodsA
• PMID 25223381

Japanese Journal

• 妊娠初期に発症したリステリア敗血症の1例

• 産婦人科の進歩 67(4), 405-409, 2015
• NAID 130005110853

• 本邦初のGemella sanguinisによる感染性心内膜炎の1例

• 医学検査 64(4), 433-440, 2015
• NAID 130005098766

• EXPLORE THE ANGIOGENESIS OF AUTOLOGOUS TRANSPLANTED BRAIN TISSUES IN RABBITS

• Microvascular Reviews and Communications 7(1), 34-34, 2014
• NAID 130004678472

Related Links

• ゲンタマイシン - Wikipedia

ゲンタマイシン（英: gentamicin, gentamycin）は、アミノグリコシド（アミノ配糖体）系 抗生物質である。 英語名称は、正式にはgentamicinという。同じアミノグリコシドの tobramycin、streptomycin、kanamycinとは意図的に異なる綴りが与えられている。 これは、 ...

• GENTAMICIN - INJECTION (Garamycin) side effects, medical uses ...

Consumer information about the medication GENTAMICIN - INJECTION ( Garamycin), includes side effects, drug interactions, recommended dosages, and storage information. Read more about the prescription drug GENTAMICIN ...

Related Pictures